
CBD in the Treatment of Insomnia and Other Sleep Disorders: What Sleep Medicine Says in 2026
CBD for insomnia, sleep apnea, and restless legs syndrome: what randomized studies showed, what AASM discourages, and why this text does not provide a dose.

CBD for insomnia, sleep apnea, and restless legs syndrome: what randomized studies showed, what AASM discourages, and why this text does not provide a dose.

What cannabinoid studies really showed in Alzheimer’s disease, where the CBD safety limit lies for seniors, and why CBD cannot replace a neurologist.

Cannabis does not cure cancer. We examine what the ASCO 2024 guidelines and Cochrane reviews say about CBD for chemotherapy nausea, pain, and palliative care.

PTSD is a disorder after trauma with established criteria and effective treatment. We check the symptoms, therapy standards, and what studies on CBD really show.

Cannabis for endometriosis: what research really shows, how the endocannabinoid system changes, and medical marijuana access in Poland.

Does CBD support intimate life? We check what studies say about cannabis, libido, pain during intercourse, and anxiety, and where evidence ends.

CBD in schizophrenia: what Leweke 2012 and McGuire 2018 studies showed, what doses were used, why THC acts oppositely, and what evidence does not confirm.

What did the study of edible cannabis in 25 oncology patients really show, what do the ASCO guidelines from 2024 recommend, and what is the access to cannabis in Poland.

Cannabinoids in neuropathic pain without marketing: Cochrane review, NeuPSIG guidelines, Hamburg study, drug interactions, and Polish Rpw prescription rules.

Psilocybin in psychotherapy: what NEJM and JAMA Psychiatry studies really showed, associated risks, and why it is listed in Schedule I-P in Poland.

Czy masz ukończone 18 lat?
Buch z Tobą